The first months of 2025 have marked a significant shift from the previous year’s performance. Following the implementation of new US tariffs — including a 10% base on all imports, 50% on the EU, 55% accumulated on China, and 24% on Japan — global markets experienced immediate turbulence. However, after the March-April correction, major indices have shown recovery toward new all-time highs.
In this dual scenario of uncertainty and rebound, investors face a key question: where to look for best long-term investment stocks that combine growth potential with resilience against trade tensions?
Identifying the Best Stocks: Beyond Past Performance
Selecting strategic equity titles requires a multidimensional analysis. Beyond historical figures, it is essential to evaluate:
Financial strength and operating margins: Companies with efficient cost structures and adaptability to regulatory pressures.
Sector positioning: Focus on industries with growing structural demand (semiconductors, healthcare, cloud technology, premium luxury).
Geographic diversification: Balance between US, European, and Asian exposure to mitigate regional risks.
Sustainable competitive advantages: Leadership in innovation, significant market shares, or access to critical resources.
Key Sectors with Sustained Growth Potential
Technology and Semiconductors: The Heart of Digital Transformation
The semiconductor sector presents clear catalysts in the medium term. ASML Holding (€30-35 billion in projected sales for 2025, record gross margin of 54%) leads EUV lithography equipment manufacturing, an indispensable technology for advanced chips. Despite a 30% decline in the past year — caused by reduced capex in Intel and Samsung — structural demand for AI and high-performance computing supports favorable outlooks.
Microsoft (fiscal 2024 revenue: $245.1 billion, 16% growth%) positions as a key beneficiary of the generative AI cycle. Its third fiscal quarter of 2025 showed revenues of $70.1 billion with Azure growth of 33%, demonstrating traction in cloud services despite valuation challenges.
The strategy of these stocks reflects bets on long-term technological infrastructure, beyond immediate business cycles.
Pharmaceuticals and Healthcare: Growing Structural Demand
Novo Nordisk illustrates both opportunities and challenges. After a 27% drop in March 2025 due to competitive pressure from Eli Lilly, the company offset this by acquiring Catalent ($16.5 billion) and licensing the drug LX9851 ($1 billion). With 2024 sales of $42.1 billion (+26%) and margins of 43%, it maintains a solid position in diabetes and obesity treatments. The stock correction offers an attractive long-term entry point.
Luxury and Discretionary Consumption: Recovery of Asian Markets
LVMH (2024 revenue: €84.7 billion, recurring operating profit €19.6 billion) faces pressure from US tariffs (20% in April, reduced to 10% until July) and demand correction in China. However, growth strategy in Japan (double-digit sales in 2024), Middle East (+6% regional), and India (new stores) suggest potential recovery. The 25% decline from all-time highs could present a selective opportunity.
Finance and Energy: Beneficiaries of Elevated Rates
JPMorgan Chase (market cap: $822.6 billion, YTD return: 23.48%) benefits from the environment of high interest rates and its leadership position in global banking. Exxon Mobil (YTD return: 4.3%, stable margins) leverages high oil prices and maintains financial discipline.
Alibaba: Potential Recovery in a Favorable Chinese Context
Alibaba Group (Q1 2025 revenue: 236.45 billion yuan, adjusted net growth 22%) executes an investment plan of $52 billion in AI and cloud infrastructure. After a 35% decline from 2024 highs, recent volatility (rose over 40% in February, then retraced) reflects complex price dynamics. However, the recovery potential in the Chinese economy reinforces medium-term prospects.
Practical Criteria for Building a Diversified Portfolio
When identifying best long-term investment stocks in a context of geopolitical tensions, consider:
Active sector diversification: Do not concentrate exposure in a single sector; balance technology, healthcare, finance, and luxury goods.
Analysis of operating margins: Companies with margins above 20-30% tend to withstand inflationary and tariff pressures better.
Innovation capacity: Seek leaders in their markets with strong R&D investment; this ensures long-term relevance.
Constant geopolitical monitoring: Tariffs, export restrictions, and regulatory changes can significantly impact; review portfolios regularly.
Gradual entry during corrections: Significant declines (20-30%) often present opportunities for patient investors with a 3-5 year horizon.
Investment Mechanisms: Stocks, Funds, and Derivatives
Investors can access these stocks through:
Direct stock purchase: Maximum control over portfolio composition; requires an account with an authorized broker.
Investment funds: Automatic diversification; ideal for investors with moderate risk tolerance.
Derivatives (CFDs): Enable leverage and hedging; require discipline and advanced knowledge.
In a high-volatility environment, a balanced mix of traditional stocks and defensive derivatives (for hedging) can optimize risk-return.
Final Reflection: Rational Investing in Uncertain Times
2025 will mark a contrast with previous years of record gains. Volatility and uncertainty now dominate. Investors building portfolios with best long-term investment stocks based on financial strength, sector leadership, and geographic diversification will be better positioned to capture recovery cycles.
Recent corrections — especially in technology, luxury, and pharmaceuticals — have created attractive entry points. The key is to maintain discipline, avoid impulsive decisions during market panics, and stay informed about political and commercial dynamics shaping the investment environment.
A diversified, well-founded, and actively monitored portfolio remains the best defensive and offensive strategy simultaneously.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Stock Investment Strategy for 2025: Navigating Commercial Uncertainty
Current Context: Volatility and Opportunities
The first months of 2025 have marked a significant shift from the previous year’s performance. Following the implementation of new US tariffs — including a 10% base on all imports, 50% on the EU, 55% accumulated on China, and 24% on Japan — global markets experienced immediate turbulence. However, after the March-April correction, major indices have shown recovery toward new all-time highs.
In this dual scenario of uncertainty and rebound, investors face a key question: where to look for best long-term investment stocks that combine growth potential with resilience against trade tensions?
Identifying the Best Stocks: Beyond Past Performance
Selecting strategic equity titles requires a multidimensional analysis. Beyond historical figures, it is essential to evaluate:
Key Sectors with Sustained Growth Potential
Technology and Semiconductors: The Heart of Digital Transformation
The semiconductor sector presents clear catalysts in the medium term. ASML Holding (€30-35 billion in projected sales for 2025, record gross margin of 54%) leads EUV lithography equipment manufacturing, an indispensable technology for advanced chips. Despite a 30% decline in the past year — caused by reduced capex in Intel and Samsung — structural demand for AI and high-performance computing supports favorable outlooks.
Microsoft (fiscal 2024 revenue: $245.1 billion, 16% growth%) positions as a key beneficiary of the generative AI cycle. Its third fiscal quarter of 2025 showed revenues of $70.1 billion with Azure growth of 33%, demonstrating traction in cloud services despite valuation challenges.
The strategy of these stocks reflects bets on long-term technological infrastructure, beyond immediate business cycles.
Pharmaceuticals and Healthcare: Growing Structural Demand
Novo Nordisk illustrates both opportunities and challenges. After a 27% drop in March 2025 due to competitive pressure from Eli Lilly, the company offset this by acquiring Catalent ($16.5 billion) and licensing the drug LX9851 ($1 billion). With 2024 sales of $42.1 billion (+26%) and margins of 43%, it maintains a solid position in diabetes and obesity treatments. The stock correction offers an attractive long-term entry point.
Luxury and Discretionary Consumption: Recovery of Asian Markets
LVMH (2024 revenue: €84.7 billion, recurring operating profit €19.6 billion) faces pressure from US tariffs (20% in April, reduced to 10% until July) and demand correction in China. However, growth strategy in Japan (double-digit sales in 2024), Middle East (+6% regional), and India (new stores) suggest potential recovery. The 25% decline from all-time highs could present a selective opportunity.
Finance and Energy: Beneficiaries of Elevated Rates
JPMorgan Chase (market cap: $822.6 billion, YTD return: 23.48%) benefits from the environment of high interest rates and its leadership position in global banking. Exxon Mobil (YTD return: 4.3%, stable margins) leverages high oil prices and maintains financial discipline.
Alibaba: Potential Recovery in a Favorable Chinese Context
Alibaba Group (Q1 2025 revenue: 236.45 billion yuan, adjusted net growth 22%) executes an investment plan of $52 billion in AI and cloud infrastructure. After a 35% decline from 2024 highs, recent volatility (rose over 40% in February, then retraced) reflects complex price dynamics. However, the recovery potential in the Chinese economy reinforces medium-term prospects.
Practical Criteria for Building a Diversified Portfolio
When identifying best long-term investment stocks in a context of geopolitical tensions, consider:
Active sector diversification: Do not concentrate exposure in a single sector; balance technology, healthcare, finance, and luxury goods.
Analysis of operating margins: Companies with margins above 20-30% tend to withstand inflationary and tariff pressures better.
Innovation capacity: Seek leaders in their markets with strong R&D investment; this ensures long-term relevance.
Constant geopolitical monitoring: Tariffs, export restrictions, and regulatory changes can significantly impact; review portfolios regularly.
Gradual entry during corrections: Significant declines (20-30%) often present opportunities for patient investors with a 3-5 year horizon.
Investment Mechanisms: Stocks, Funds, and Derivatives
Investors can access these stocks through:
In a high-volatility environment, a balanced mix of traditional stocks and defensive derivatives (for hedging) can optimize risk-return.
Final Reflection: Rational Investing in Uncertain Times
2025 will mark a contrast with previous years of record gains. Volatility and uncertainty now dominate. Investors building portfolios with best long-term investment stocks based on financial strength, sector leadership, and geographic diversification will be better positioned to capture recovery cycles.
Recent corrections — especially in technology, luxury, and pharmaceuticals — have created attractive entry points. The key is to maintain discipline, avoid impulsive decisions during market panics, and stay informed about political and commercial dynamics shaping the investment environment.
A diversified, well-founded, and actively monitored portfolio remains the best defensive and offensive strategy simultaneously.